These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2718200)

  • 1. Effect of therapy on platelet activating factor-induced aggregation in acute stroke.
    Joseph R; Welch KM; D'Andrea G
    Stroke; 1989 May; 20(5):609-11. PubMed ID: 2718200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of chronic antiplatelet treatment on platelet activating factor-induced platelet activity in stroke].
    Han E; Joseph R; Grunfeld S; Welch KM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Feb; 24(1):21-3, 61. PubMed ID: 1868762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
    Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
    Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
    Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
    Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
    Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
    Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
    Lenz TL; Hilleman DE
    Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
    Heptinstall S; Fox S; Crawford J; Hawkins M
    Thromb Res; 1986 Apr; 42(2):215-23. PubMed ID: 3715801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stroke, platelet activating factor and receptor antagonists].
    Wang ZG; Wang DQ; Jiao Y; Tian X; Sun MY
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4750-4755. PubMed ID: 29493142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke.
    Lim ST; Murphy SJX; Murphy SM; Coughlan T; O'Neill D; Tierney S; Egan B; Collins DR; McCarthy AJ; Lim SY; Smith DR; Cox D; McCabe DJH
    J Neurol Sci; 2022 Oct; 441():120334. PubMed ID: 36030623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination.
    Akopov SE; Gabrielian ES
    Eur J Clin Pharmacol; 1992; 42(3):257-9. PubMed ID: 1577042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
    Harbison JW
    Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S17-20. PubMed ID: 9784798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyridamole plus aspirin in cerebrovascular disease.
    Cohen SN
    Arch Neurol; 2000 Jul; 57(7):1086-7. PubMed ID: 10892000
    [No Abstract]   [Full Text] [Related]  

  • 17. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-platelet therapy in ischemic cerebrovascular disorder--clinical and hematological study].
    Yoshii K; Seki Y; Aiba T; Tsukada T; Shiozawa R
    No To Shinkei; 1985 Oct; 37(10):985-90. PubMed ID: 4074576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke.
    Zhao L; Fletcher S; Weaver C; Leonardi-Bee J; May J; Fox S; Willmot M; Heptinstal S; Bath P
    Thromb Haemost; 2005 Mar; 93(3):527-34. PubMed ID: 15735805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.